↓ Skip to main content

Phase i trialist

Overview of attention for article published in Lancet Oncology, March 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
20 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase i trialist
Published in
Lancet Oncology, March 2012
DOI 10.1016/s1470-2045(12)70098-0
Pubmed ID
Authors

Jacob Scott

X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 25%
Professor > Associate Professor 2 25%
Student > Ph. D. Student 1 13%
Researcher 1 13%
Student > Postgraduate 1 13%
Other 0 0%
Unknown 1 13%
Readers by discipline Count As %
Mathematics 2 25%
Medicine and Dentistry 2 25%
Economics, Econometrics and Finance 1 13%
Agricultural and Biological Sciences 1 13%
Unknown 2 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2023.
All research outputs
#2,566,544
of 25,374,917 outputs
Outputs from Lancet Oncology
#2,428
of 6,882 outputs
Outputs of similar age
#14,758
of 168,139 outputs
Outputs of similar age from Lancet Oncology
#24
of 98 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,882 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,139 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.